Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma.

Brain tumor pathology - 1 Jul 2021

Osada Yoshinari, Saito Ryuta, Miyata Satoshi, Shoji Takuhiro, Shibahara Ichiyo, Kanamori Masayuki, Sonoda Yukihiko, Kumabe Toshihiro, Watanabe Mika, Tominaga Teiji

Abstract excerpt

In previous studies, isocitrate dehydrogenase (IDH) mutations were associated with tumor-associated epilepsy (TAE) and venous thromboembolism (VTE). We examined the relationship between IDH mutations in grade II/III astrocytomas and TAE/VTE according to the 2016 World Health Organization classification. The clinical data of patients with newly diagnosed grade II/III gliomas who were treated at Tohoku University...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Astrocytoma
Share to Brain Neoplasms

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Decision Trees

Share to Epilepsy

Share to Isocitrate Dehydrogenase

Share to Multivariate Analysis

Share to Neoplasm Grading

Share to Venous Thromboembolism

Source

Identifiers

PMID: 34269949
DOI: 10.1007/s10014-021-00406-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between IDH mutational status and tumor-associated epilepsy or venous thromboembolism in patients with grade II and III astrocytoma.PMID 34269949Read ↗

IDH mutation status and the development of venous thromboembolism in astrocytoma patients.Semantic proximity Read ↗

Isocitrate dehydrogenase mutation and risk of venous thromboembolism in glioma: A systematic review and meta-analysis.Semantic proximity Read ↗

Assessment of venous thromboembolism in adult diffuse-type gliomas: an experience of a quaternary center and a systematic reviewSemantic proximity Read ↗

Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype.Semantic proximity Read ↗

Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis.Semantic proximity Read ↗

Determining venous thromboembolism risk in patients with adult-type diffuse glioma.Semantic proximity Read ↗

Association Between IDH1 and IDH2 Mutations and Preoperative Seizures in Patients with Low-Grade Versus High-Grade Glioma: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort studySemantic proximity Read ↗

Seizures in patients with IDH-mutated lower grade gliomas.Semantic proximity Read ↗

Prognostic Factors in Lobar World Health Organization Grade II Astrocytomas.Semantic proximity Read ↗

Mutant IDH1 and thrombosis in gliomas.Semantic proximity Read ↗

Combined analysis of clinical and laboratory markers to predict the risk of venous thromboembolism in patients with IDH1 wild-type glioblastoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.